After 13 years dedication into new drug development, Oneness Biotech has become a leading biotech in Taiwan. Quantum International Corp. (QIC) is an expert in capital market and has conducted an interview for the “CEO Conversation” in August 2021. Mr. William Lu, the founder of Oneness Biotech has shared an insight into the new drug development and the core value of the company.
Generally, about 19-34% of diabetic patients develop foot ulcers, which often results in amputation. However, FESPIXON® brings new healing possibilities for DFUs. In the July 2022 QIC's “CEO Conversation” exclusive interview with, Vice President Dr. Shyi-Gen Chen, he shared how to utilize past experience with DFU treatments in the development and application of new drugs, as well as talked about the potential and development of FESPIXON®.